| Literature DB >> 32236875 |
Francisco de la Cerda-Ojeda1, Juan D González-Rodríguez2, Leire Madariaga3, Guillermo Martínez-Díaz-Guerra4, María L Matoses-Ruipérez5.
Abstract
Hypophosphataemic rickets (HR) is a group of rare disorders caused by excessive renal phosphate wasting in which the participation of fibroblast growth factor 23 (FGF23) can be prominent. These diseases pose therapeutic challenges with important consequences for growth and bone development in childhood, with higher risk of fractures and poorer bone healing, dental problems, and nephrolithiasis or nephrocalcinosis. In some cases, the diagnostic delay can be very long; laboratory findings and an exhaustive anamnesis could help distinguish between various pathologies, and FGF23 values-although currently not routinely measured-have implications for the differential diagnosis. Genetic testing is encouraged, especially in sporadic or insidious cases. In this review we discuss the clinical features of HR, with a particular emphasis on the differential diagnosis and the therapeutic implications.Entities:
Keywords: Cutaneous skeletal hypophosphataemia syndrome; Differential diagnosis; Hypophosphataemic rickets; McCune–Albright syndrome; Oncogenic osteomalacia; Orthopaedics
Mesh:
Substances:
Year: 2020 PMID: 32236875 DOI: 10.1007/s12325-019-01182-3
Source DB: PubMed Journal: Adv Ther ISSN: 0741-238X Impact factor: 3.845